Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Immunotherapy for Advanced HPV-Associated and Gastrointestinal Cancers
NCT04708470Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2021
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat, NHS-IL-12, bintrafusp alfa in HPV-associated cancer, small bowel cancer, colorectal cancer (CRC), sponsored by National Cancer Institute. Started Oct 2021; status: completed.
02
Drugs
entinostatNHS-IL-12bintrafusp alfa
03
Conditions
HPV-associated cancersmall bowel cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04708470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04708470.